This inventor holds 10 USPTO granted patents, plus 1 CIPO patent. Top assignees: Washington University, Smithkline Beckman Corporation. Active years: 1987-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-2019
Title: The Innovations of Garland R. Marshall
Introduction
Garland R. Marshall is a prominent inventor based in Clayton, MO (US), known for his significant contributions to the field of biochemistry and pharmacology. With a total of 10 patents to his name, he has made remarkable strides in developing innovative treatments for various diseases.
Latest Patents
One of his latest patents focuses on isoform-selective lysine deacetylase inhibitors. These inhibitors are crucial as they target the lysine deacetylase enzyme, which has potential applications as antitumor drugs and in treating conditions such as addiction, asthma, cardiovascular disease, immunosuppression, neurodegenerative diseases, sepsis, sickle-cell disease, uveal melanoma, and the termination of viral latency, particularly HIV-1 latency. Another significant patent involves methods for using KDAC inhibitor compounds in the treatment of various parasitic diseases, showcasing his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Garland has worked with esteemed institutions, including Washington University and SmithKline Beecham Corporation. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options in medicine.
Collaborations
Garland has collaborated with notable colleagues such as Mihaly V. Toth and Michael L. Moore, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Garland R. Marshall's contributions to science and medicine through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile